Boji Medical Technology Co.,Ltd. (SHE:300404)
China flag China · Delayed Price · Currency is CNY
12.10
+0.21 (1.77%)
Nov 5, 2026, 4:00 PM EST

Boji Medical Technology Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
998.66851.18723.92541.59411.06314.65
Other Revenue
17.4617.4618.114.2412.629.55
1,016868.64742.02555.83423.68324.2
Revenue Growth
31.93%17.07%33.50%31.19%30.69%24.47%
Cost of Revenue
771.91636.41517.98373.34267.57185.56
Gross Profit
244.21232.23224.04182.49156.11138.64
Selling, General & Admin
120.1123.56124.44108.9988.6571.19
Research & Development
54.9557.562.5954.9743.6827.65
Other Operating Expenses
14.37.246.623.242.82.27
Operating Expenses
217.41214.73214.03182.56150.05109.43
Operating Income
26.817.510-0.076.0629.22
Interest Expense
-1.36-1.68-3.19-1.53-0.7-1.41
Interest & Investment Income
13.931.674.284.333.644.21
Currency Exchange Gain (Loss)
0.070.070-0.01-0.01-0.01
Other Non Operating Income (Expenses)
0.3-0.5-2.34-0.59-0.41-0.4
EBT Excluding Unusual Items
39.7317.068.762.128.5831.61
Gain (Loss) on Sale of Investments
2.311.481.060.591.79-
Gain (Loss) on Sale of Assets
-0.24--0.210--
Asset Writedown
4.21-0.01-0.08-0.03-0.07-0.3
Other Unusual Items
15.0511.528.8914.9514.2715.78
Pretax Income
61.0530.0618.4217.6324.5747.09
Income Tax Expense
3.66-2.85-12.24-9.56-4.743.59
Earnings From Continuing Operations
57.3932.9130.6627.1929.3143.5
Minority Interest in Earnings
0.48-2.42-1.88-2.85-1.64-4.62
Net Income
57.8830.4928.7824.3427.6738.88
Net Income to Common
57.8830.4928.7824.3427.6738.88
Net Income Growth
680.74%5.97%18.23%-12.04%-28.84%128.87%
Shares Outstanding (Basic)
386384382370367349
Shares Outstanding (Diluted)
386384383371367349
Shares Change
0.52%0.36%3.14%0.97%5.18%10.02%
EPS (Basic)
0.150.080.080.070.080.11
EPS (Diluted)
0.150.080.080.070.080.11
EPS Growth
676.72%5.58%14.63%-12.88%-32.34%108.04%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
48.4968.3-2.57-26.24-89.59-23.89
Free Cash Flow Per Share
0.130.18-0.01-0.07-0.24-0.07
Dividend Per Share
0.0130.0130.0120.0100.0100.014
Dividend Growth
8.33%8.33%20.00%0%-30.07%-
Gross Margin
24.03%26.73%30.19%32.83%36.85%42.77%
Operating Margin
2.64%2.02%1.35%-0.01%1.43%9.01%
Profit Margin
5.70%3.51%3.88%4.38%6.53%11.99%
Free Cash Flow Margin
4.77%7.86%-0.35%-4.72%-21.15%-7.37%
EBITDA
53.343.1634.5320.424.9946.03
EBITDA Margin
5.25%4.97%4.65%3.67%5.90%14.20%
D&A For EBITDA
26.525.6524.5220.4718.9316.81
EBIT
26.817.510-0.076.0629.22
EBIT Margin
2.64%2.02%1.35%-0.01%1.43%9.01%
Effective Tax Rate
5.99%----7.62%
Revenue as Reported
1,016868.64742.02555.83423.68324.2
Advertising Expenses
-2.612.291.850.710.65